Safety and efficacy of peptide receptor radionuclide therapy with (177)Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors

Rationale: This study aimed to assess the safety, efficacy, and survival of (177)Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors (NETs). Methods: Thirty patients with metastatic NETs were prospectively enrolled and treated with (177)Lu-DOTA-EB-TATE (3 intended cycles at 8 to 12-wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuanyuan, Liu, Qingxing, Wang, Guochang, Sui, Huimin, Wang, Rongxi, Wang, Jiarou, Zhang, Jingjing, Zhu, Zhaohui, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516233/
https://www.ncbi.nlm.nih.gov/pubmed/36185603
http://dx.doi.org/10.7150/thno.77219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516233/
https://www.ncbi.nlm.nih.gov/pubmed/36185603
http://dx.doi.org/10.7150/thno.77219

Ejemplares similares